ZVRA
HOLD / NEUTRALMeanRevComposite
52.50
Technical
23.40
Fundamental
62.20
Rank
—
Price
10.26
Hurst
0.26
As of
Nov 4, 2026
Daily
Zevra Therapeutics Inc.
HEALTHCAREBIOTECHNOLOGYZevra Therapeutics is a biopharmaceutical firm focused on rare diseases that operates from Celebration, Florida. The company discovers and develops proprietary prodrug candidates intended to address serious medical conditions within the United States market.
Market cap
$609.3M
P/E (trailing)
11.15
P/E (forward)
9.52
PEG ratio
10.67
Dividend yield
—
Beta
0.99
52w range
8.01 – 15.04
Return on equity
+34.80%
Profit margin
+42.80%
Revenue growth
+53.30%
Earnings growth
-88.40%
Price history
1Y: 10.26 (+0.8%) · range 8.10–14.75
Cycle position
31/ 100 cycle scoreAPPROACHING ENTRY
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 60 · MODERATE · exit proximity 0
Conviction
49/ 100 · maturity 43%
VScore.2238
Buildup.2635
EMA entry setup.3260
Fundamentals.1962
Volume profile
POC
11.41
Price vs POC
-10.1%
Overhead supply
82%
Runway
+0.8%
Value area 10.05–13.25 · 82% of 120d volume overhead · heavy supply
Get an AI analyst's read on this ticker.Open the AI analyst
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| earnings-surprise | 0.967 | Nov 4, 2026 |
| trader-sentiment | 0.690 | Nov 3, 2026 |
Pattern & cluster
Pattern
NEUTRAL
Cluster
NEUTRALForward returns
Not yet labeled — the study prices these as positions mature.